CV Sciences, Inc. Announces Launch of CV Defense Daily Immune Support

CV Defense now available on CV Sciences website and launching on Amazon.com next week

SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced its continued expansion into condition specific dietary supplements with the launch of CV Defense, the second of several products to be launched under its new Immunity product line, following the launch of CV Acute in August. 

The expansion of CV Sciences’ non-CBD Immunity product line will continue to open markets and sales channels for the Company, including major e-commerce retailers not currently accessible by CBD-based products. CV Defense is now available on CV Sciences’ website (https://www.cvsciences.com/) and will be available next week on Amazon.com.

Michael D. Lewis, MD, MPH, Colonel (Retired), U.S. Army, and CV Sciences Medical Advisor who participated in product development commented, “The fall and winter of 2020/2021 is shaping up to be one of the most challenging times that we have experienced in global public health. Now is the time to commit to fortifying the immune system with healthy lifestyle habits and science-backed supplementation provided by CV Sciences new immune products - CV Defense and CV Acute.”

CV Defense is a clinically supported immune formula that provides effective daily support for barrier immunity, innate immunity, and adaptive immunity. CV Sciences’ team of doctors and scientists formulated this product with specific intent — to fortify daily immune health. 

Based on PEA (palmitoylethanolamide), a clinically researched ingredient to support the immune system, and combined with time-tested nutrients and botanicals, including vitamins A and D, the minerals selenium and zinc, and an Organic Reishi Mushroom Extract with concentrated β-glucans, CV Defense incorporates unique ingredients able to optimize immune response.

In 1993, Nobel laureate Dr. Rita Levi-Montalcini discovered that PEA is used in the body to regulate certain immune cells in parallel with the endocannabinoid (ECS) system. These natural PEA levels can be supplemented by CV Defense through daily use. More than 3,000 participants took part in six double-blind, placebo-controlled clinical trials demonstrating that PEA has clear benefits for immune health. In addition to studies on immune health, multiple studies have demonstrated that PEA is safe and effective in supporting a balanced inflammatory response and improved gut barrier defense.